Five bullish things for MNTA that could occur at any time (options players beware): • FDA approval of generic Copaxone. • A partnership deal for an FoB program. • A partnership deal for M402 (or, less likely, for M118). • Monetization of MNTA’s Lovenox income stream. • A buyout offer.